Natraceutical will buy Braes group (Obipektin)

Friday 13th of May 2005

Natraceutical announced that they will purchase the Braes group for Euro 80 million. The Braes group includes the Swiss pectin and fruit/vegetable processing company Obipektin and the Overseal company.